Ann Tivey

1.2k total citations · 1 hit paper
11 papers, 282 citations indexed

About

Ann Tivey is a scholar working on Cancer Research, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ann Tivey has authored 11 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ann Tivey's work include Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Palliative Care and End-of-Life Issues (1 paper). Ann Tivey is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Palliative Care and End-of-Life Issues (1 paper). Ann Tivey collaborates with scholars based in United Kingdom, Australia and Canada. Ann Tivey's co-authors include Dominic G. Rothwell, Caroline Dive, Matt Church, Natalie Cook, Rebecca Lee, Paul Lorigan, Luke Moore, Alison Holmes, Esmita Charani and Timothy M. Rawson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Nature Reviews Clinical Oncology.

In The Last Decade

Ann Tivey

9 papers receiving 279 citations

Hit Papers

Circulating tumour DNA — looking beyond the blood 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Tivey United Kingdom 5 154 96 94 76 43 11 282
Brittany Bychkovsky United States 11 107 0.7× 139 1.4× 40 0.4× 35 0.5× 53 1.2× 37 286
Camila Ordóñez‐Reyes Colombia 7 46 0.3× 76 0.8× 45 0.5× 46 0.6× 11 0.3× 19 168
Matt Church United Kingdom 4 135 0.9× 73 0.8× 112 1.2× 75 1.0× 38 0.9× 5 350
Doru Paul United States 9 57 0.4× 221 2.3× 100 1.1× 64 0.8× 40 0.9× 33 401
Mark R. Openshaw United Kingdom 11 86 0.6× 92 1.0× 90 1.0× 46 0.6× 52 1.2× 27 350
Zi Liu China 12 70 0.5× 99 1.0× 87 0.9× 38 0.5× 17 0.4× 24 310
Shu-Lian Wang China 4 106 0.7× 155 1.6× 29 0.3× 39 0.5× 52 1.2× 6 230
Samuel J Haryono Indonesia 8 72 0.5× 93 1.0× 86 0.9× 17 0.2× 41 1.0× 20 267
Brenda Rosales Australia 7 203 1.3× 181 1.9× 110 1.2× 89 1.2× 42 1.0× 27 366
Jing Si China 10 204 1.3× 80 0.8× 168 1.8× 28 0.4× 32 0.7× 18 345

Countries citing papers authored by Ann Tivey

Since Specialization
Citations

This map shows the geographic impact of Ann Tivey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Tivey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Tivey more than expected).

Fields of papers citing papers by Ann Tivey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Tivey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Tivey. The network helps show where Ann Tivey may publish in the future.

Co-authorship network of co-authors of Ann Tivey

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Tivey. A scholar is included among the top collaborators of Ann Tivey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Tivey. Ann Tivey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tivey, Ann, Rebecca Lee, Alexandra Clipson, et al.. (2024). Mining nucleic acid “omics” to boost liquid biopsy in cancer. Cell Reports Medicine. 5(9). 101736–101736. 10 indexed citations
3.
Olsson‐Brown, Anna, Mark Baxter, Laura Feeney, et al.. (2022). The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.. Journal of Clinical Oncology. 40(16_suppl). 2522–2522.
4.
Tivey, Ann, et al.. (2022). Circulating Tumour DNA in Melanoma—Clinic Ready?. Current Oncology Reports. 24(3). 363–373. 24 indexed citations
5.
Tivey, Ann, Matt Church, Dominic G. Rothwell, Caroline Dive, & Natalie Cook. (2022). Circulating tumour DNA — looking beyond the blood. Nature Reviews Clinical Oncology. 19(9). 600–612. 194 indexed citations breakdown →
6.
Martínez‐Calle, Nicolás, Amy A. Kirkwood, Maxine Lamb, et al.. (2021). Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort. Advances in Therapy. 38(7). 3789–3802. 3 indexed citations
7.
Tivey, Ann, et al.. (2021). Patient Engagement in Melanoma Research: From Bench to Bedside. Future Oncology. 17(28). 3705–3716. 4 indexed citations
8.
Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2021). Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.. Journal of Clinical Oncology. 39(15_suppl). 12026–12026. 5 indexed citations
9.
Tivey, Ann, Rohan Shotton, Rebecca Lee, et al.. (2020). 1722P Longitudinal analysis of biochemical and haematological features of cancer patients with COVID-19. Annals of Oncology. 31. S1011–S1011. 1 indexed citations
10.
Tivey, Ann, et al.. (2020). Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy?. Journal of Geriatric Oncology. 11(7). 1154–1156. 4 indexed citations
11.
Rawson, Timothy M., Luke Moore, Ann Tivey, et al.. (2017). Behaviour change interventions to influence antimicrobial prescribing: a cross-sectional analysis of reports from UK state-of-the-art scientific conferences. Antimicrobial Resistance and Infection Control. 6(1). 11–11. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026